Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)193.62
  • Today's Change0.68 / 0.35%
  • Shares traded3.93m
  • 1 Year change+26.15%
  • Beta0.6213
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue54,31858,05456,197
OPERATING EXPENSES
Cost of revenue total18,22616,52717,314
Selling, general and admin. expenses, total12,68014,86111,996
Depreciation/amortization------
Unusual expense(income)3,7962,0061,549
Other operating expenses, total(179)56432
Total operating expense41,56139,93738,273
Operating income12,75718,11717,924
Other, net(4677)(2448)(2500)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6,25013,47712,989
Provision for income taxes1,3771,6321,440
Net income after taxes4,87311,84511,549
Minority interest(10)(9)(7)
Net income before extra. Items4,86311,83611,542
Total extraordinary items------
Net income4,86311,83611,542
Inc.avail. to common excl. extra. Items4,82011,78211,468
Inc.avail. to common incl. extra. Items4,82011,78211,468
EPS RECONCILIATION
Basic/primary weighted average shares1,7681,7711,770
Basic/primary eps excl. extra items2.736.656.48
Basic/primary eps incl. extra items2.736.656.48
Dilution adjustment------
Diluted weighted average shares1,7731,7781,777
Diluted eps excl. extra items2.726.636.45
Diluted eps incl. extra items2.726.636.45
COMMON STOCK DIVIDENDS
DPS - common stock primary issue5.925.645.20
Gross dividend - common stock10,64710,1799,470
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2,2242,2302,423
SUPPLEMENTAL INCOME
Depreciation, supplemental752778803
Total special items3,9282,2471,608
NORMALISED INCOME
Normalized income before taxes10,17815,72414,597
Effect of special items on income taxes69418872
Income tax excluding impact of special items2,0711,8201,512
Normalized income after tax8,10713,90413,085
Normalized income avail. to common8,05413,84113,004
Basic normalized EPS4.567.827.35
Diluted normalized EPS4.547.787.32
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.